Clinical Trial Update: Safety and Efficacy of ONT01 in Lupus [EARLY_Phase 1]

View source ↗

Summary

ONT01 is in an early Phase 1 trial for lupus nephritis and systemic lupus erythematosus and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• ONT01 (ONT01)

Snippet

Sponsor: Hospital for Special Surgery, New York | Conditions: Lupus Nephritis (LN), Lupus Nephritis - WHO Class III | EARLY_Phase 1 | Status: RECRUITING